RPMVX
Price
$17.39
Change
+$0.02 (+0.12%)
Updated
Jul 16 closing price
Net Assets
112.38M
VMVIX
Price
$65.16
Change
+$0.31 (+0.48%)
Updated
Jul 16 closing price
Net Assets
30.57B
Interact to see
Advertisement

RPMVX vs VMVIX

Header iconRPMVX vs VMVIX Comparison
Open Charts RPMVX vs VMVIXBanner chart's image
Reinhart Mid Cap PMV Adv
Price$17.39
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets112.38M
Vanguard Mid-Cap Value Index Investor
Price$65.16
Change+$0.31 (+0.48%)
VolumeN/A
Net Assets30.57B
RPMVX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RPMVX vs. VMVIX commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RPMVX is a Hold and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. RPMVX (112M). VMVIX pays higher dividends than RPMVX: VMVIX (2.14) vs RPMVX (0.74). RPMVX was incepted earlier than VMVIX: RPMVX (13 years) vs VMVIX (19 years). RPMVX (1.36) is less costly to investors than VMVIX (0.19). VMVIX is a more actively managed with annual turnover of: 19.00 vs. RPMVX (18.00). VMVIX has a lower initial minimum investment than RPMVX: VMVIX (3000) vs RPMVX (5000). VMVIX annual gain was more profitable for investors over the last year : 4.51 vs. RPMVX (-3.36). VMVIX return over 5 years is better than : 66.84 vs. RPMVX (42.85).
RPMVXVMVIXRPMVX / VMVIX
Total Expense Ratio1.050.19553%
Annual Report Gross Expense Ratio1.360.19716%
Fund Existence13 years19 years-
Gain YTD-1.4751.893-78%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets112M30.6B0%
Annual Yield % from dividends0.742.1434%
Returns for 1 year-3.364.51-75%
Returns for 3 years4.9026.9818%
Returns for 5 years42.8566.8464%
Returns for 10 years28.1084.0133%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INBX23.650.69
+3.01%
Inhibrx Biosciences Inc.
ALGS8.680.18
+2.12%
Aligos Therapeutics Inc
OCSL14.610.16
+1.11%
Oaktree Specialty Lending Corp
WTFCM25.00N/A
N/A
Wintrust Financial Corp
CMA61.14-0.09
-0.15%
Comerica